Nov./Dec. 2009

The Year Ahead

November 10, 2009

Looking back to the varying changes and pressures the industry has endured, and ahead to how the industry will need to reinvent itself to continue to prosper, companies are adapting to longer-term marketplace trends and evolving patient needs. The industry is facing pressure from the economic, regulatory, and R&D environments. The industry’s movement toward transformation […]

The Safety First Era

November 10, 2009

The classwide requirement for Risk Evaluation and Mitigation Strategies (REMS) for opioid products is likely to have a profound impact on the pharmaceutical industry and healthcare. While most REMS involve only a medication guide — which is likely to have little impact on the prescribing process — experts say the Food and Drug Administration’s classwide […]

Online Media: Will it Kill the Mass Media Stars?

November 10, 2009

Jeff Baker is President and CEO, Noble Marketing Group, a provider of PhRMA-compliant creative marketing solutions for pharmaceutical, ­biotechnology, and healthcare providers. For more information, visit gonoblerx.com. “There will be more focus on education ­versus branding, and because of the guideline changes, there is a lack of tools to distribute the message and excite the […]

Social Media

November 10, 2009

Arecent Manhattan Research report states that 88% of all physicians use the Internet to access pharmaceutical, biotech, and medical device information, and 41% of all the research that physicians conduct is now done online. Nielsen’s online data show that about half of the U.S. population visited a social networking Website in the last year. The […]

The Salesforce of the Future

November 10, 2009

Our experts agree: the salesforce of the future will be more specialized, more technically advanced, and more clinically savvy; oh, and there will be fewer feet on the street, finally. If the past year is any indication, the salesforce of the future is going to experience an extreme makeover. For one, it will be much […]

RNAI Technology

November 10, 2009

Coming of Age: RNAi Technology As advances in genetics ­continue to improve our understanding of ­disease, RNAi will have the opportunity to create entirely new classes of medicines. Researchers say RNA-based therapeutic technology will have a tremendous impact on pharmaceutical research in the next five to 10 years. RNAi (RNA interference) represents a breakthrough in […]

The Innovation Challenge

November 10, 2009

There has been a great deal of discussion related to the challenges­ ­hampering innovation to create differentiated medicines. Never before have research and cutting-edge science been more important to ensure a steady flow of innovation. Much has been made of the industry’s decline in R&D productivity over the last few years. While the number of […]

R&D Business Models

November 10, 2009

The Changing R&D Business Model Companies throughout the industry are experimenting with new models designed to tackle the pipeline productivity challenge. harmaceutical research and development is facing many pressures, from decreased productivity to the impact of the economy to changing technology to an increasingly global environment. Companies are looking for solutions, but industry experts say […]

Emerging Markets Poised for Growth

November 10, 2009

Emerging markets are growing in size and in importance for drug developers. Countries outside the traditional markets of the United States, Europe, and Japan are revamping their regulatory and legal systems and reforming their healthcare systems, and they are expected to contribute more to the global pharmaceutical industry. The seven “pharmerging” markets that IMS Health […]

Reform, Consolidation, and Good Citizenry

November 10, 2009

Reform, Consolidation, and Good Citizenry Our experts featured in this issue identify healthcare reform, mergers and acquisitions, and corporate reputation as three of the many market changers that will impact how the industry does business in the future. Healthcare Reform: What’s to Come? The year-long legislative endeavor to create a healthcare reform bill that all […]

Supply Chain Strategies

November 10, 2009

Companies need to evaluate their business through their value streams rather than by individual processes or components. ccording to Bob Silvers, managing director, at SSA & Co., by applying the rigors of Lean Six Sigma to underperforming areas, pharmaceutical companies can completely transform their supply chain and operating performance and deliver substantial benefits to the […]

The Executive Suite

November 10, 2009

Meeting challenges head-on David E. I. Pyott, CBE Chairman of the Board and CEO Allergan Inc. Allergan draws stability, strength, and value from its growth equation — a business model that balances diverse specialties with a focused approach and a leadership presence in markets around the globe. R&D is the center of the enterprise and […]

The Crystal Ball

November 10, 2009

We asked our readers to identify the top trends and market shapers they expect to define the various industry sectors in the coming year. Some of their responses may already be on your radar, while others may provide a new and ­different perspective. There’s little doubt that 2010 will be another year punctuated by continued […]

Talent Pool

November 10, 2009

Pharmaceutical POOL Stanley BARSHAY Dr. Richard BOWLES Richard CLARK Willie DEESE Kenneth FRAZIER Dr. Peter KIM Raul KOHAN Merck Unveils Post-Merger Organizational Structure Merck has announced its new organizational structure following the completion of its merger with Schering-Plough. The new Merck has five primary divisions: Global Human Health, Animal Health, Consumer Health Care, Merck Research […]

On the Calendar

November 9, 2009

November 16-17 Pharmaceutical Coverage & Reimbursement Conference Washington, D.C. Q1 Productions, q1productions.com November 16-17 The 3rd Pediatric Clinical Trials Grand Hyatt Washington, Washington, D.C. ExL Pharma, exlpharma.com November 17-18, 2009 13th Advanced Forum on Structuring, Negotiating and Managing Pharma/Biotech Collaborative Agreements Helmsley Park Lane Hotel, New York American Conference Institute, americanconference.com November 18-20 2009 HBA […]

Index

November 9, 2009

Julian Adams, Ph.D. President, Research and ­Development and Chief Scientific Officer, Infinity ­Pharmaceuticals Inc. Brent Ahrens. General Partner, Canaan Partners Kenneth C. Aldrich. CEO, Chairman, and Co-Founder, ­International Stem Cell Corp. Meryl Allison. Principal, Deloitte Consulting Karla Anderson. Managing Director, Pharmaceuticals and Life-Sciences, Advisory Services Group, PricewaterhouseCoopers Kelly Andrews. Director, Strategic Planning, MicroMass Sam Azoulay. […]

PharmaTrax

November 9, 2009

Service Consolidation Recommended for Clinical trial Offices Emerging centralized clinical trial offices (CTOs) are among the newest developments within the research administration infrastructure of academic health centers. Little uniformity exists in the structure or functions of existing CTOs, however, and a recent report says that models are needed for the future. According to the Association […]

E-Media

November 9, 2009

IMS Health’s Ask IMS is a cost-effective, Web-based service that provides strategic market intelligence to help drive the growth and success of early-stage biopharmaceutical companies. Drawn from IMS’ comprehensive pharmaceutical market information, Ask IMS offers timely decision-making support for understanding critical market opportunities and issues, as well as for planning and executing successful commercialization strategies. […]

What’s New

November 9, 2009

inVentiv Health’s recently launched risk evaluation and mitigation strategy (REMS) offering provides pharmaceutical and biotechnology clients with a customizable suite of REMS-related services that can be delivered through a single, integrated program. In an effort to assure safe use of prescription drug products, the FDA now requires pharmaceutical companies to submit a REMS for select […]

UpFront

November 9, 2009

In Memoriam Linda Ley Ciccarelli Linda Ciccarelli, VP and senior director of media services at Sudler & Hennessey, passed away on Sunday, Sept. 27, 2009, at her home in Wakefield, R.I. A founding member of the Association of Healthcare Media Directors (AHMD), Ms. Ciccarelli was a longtime leader in the field of medical media. She […]

Letter from the Editor

November 9, 2009

2010 — Time to Move Forward The consensus is pretty clear: 2009 is best left behind. People began writing off this year back in June and started setting their sights on first-quarter 2010. Fiscal projections aside, this Gregorian leapfrog of the calendar was more of a mindset throughout the industry: Let’s just get to the […]

Brave New Digital World

October 27, 2009

Pharma companies must be bold and confident in their deployment of electronic solutions or risk being left behind on the technological superhighway.

Four Tips for Better Physician Recruitment

October 27, 2009

Qi, part of CommonHealth

Creating a Better Electronic Compliance Program

October 27, 2009

Qi, part of CommonHealth

Mobile Marketing for Pharma: An Innovation Lab* Whitepaper

October 27, 2009

Compass Healthcare Communications

Just-in-Time Information Finally Arrives

October 27, 2009

AmerisourceBergen Specialty Group

FEEDBACK